Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

June 30, 2000

Conditions

Renal CirculationRenal Plasma FlowGlomerular Filtration RateFatty Acids, Nonesterified

Interventions

DRUG

NG-monomethyl-L-Arginine (L-NMMA)

DRUG

triglycerides (Intralipid 20%)

DRUG

heparin

DRUG

somatostatin

DRUG

insulin

DRUG

glucose

DRUG

inulin

DRUG

paraamino hippurate (PAH)

Trial Locations (1)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT00431665 - Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters | Biotech Hunter | Biotech Hunter